HempFusion Announces USDA Organic Certification for Its CBD Tinctures
January 12 2021 - 7:05AM
Business Wire
HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the
“Company”), a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition, is pleased to
announce that it has received USDA Organic Certification for its
HempFusion CBD tinctures ranging in potency from 150mg (5mg per
serving) to 1500mg (50mg per serving) of CBD per bottle, making
HempFusion one of the first publicly traded CBD companies to
achieve such distinction.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210112005349/en/
HempFusion 50mg USDA Organic Certified
CBD (Graphic: Business Wire)
“Our team has worked meticulously to earn USDA Organic
Certification, which supports our commitment to providing consumers
with premium and differentiated CBD products as well as new
potential distribution points,” commented Jason Mitchell, N.D.,
HempFusion’s Co-founder and Chief Executive Officer. “This
prestigious certification joins our many other compliance markers,
further establishing HempFusion as a leader in the premium CBD
category.”
HempFusion began the process to certify its tincture as USDA
Organic in 2018, as organic products generally represent some of
the highest quality and prestigious products on store shelves
today.
USDA Organic certification is a rigorous process that involves
detailed documentation for every step in the growth, production and
manufacturing process, from what is in the soil and how the hemp is
grown and extracted, to how the finished products are manufactured
and bottled. At all times, the Company is required to demonstrate
its ability to meet rigorous organic standards with respect to its
CBD tinctures, including undergoing independent facility and
documentation audits to both earn and maintain the right to use the
USDA Organic seal.
“We’ve also expanded our tincture family to include two new SKUs
catering to consumers who are looking for more CBD per serving.
These new products offer 30 and 50mg of CBD per serving or 900 and
1500mg of CBD per bottle, respectively, providing an even wider
variety of choices,” commented Ola Lessard, HempFusion’s Chief
Marketing Officer, who also serves as President of the US Hemp
Roundtable.
HempFusion’s family of brands are available through
approximately 4,000 retailers across all 50 states of the United
States and select international locations and from the Company’s
website at HempFusion.com.
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition. HempFusion
distributes its family of brands, including HempFusion, Probulin
Probiotics, Biome Research, and HF Labs, to approximately 4,000
retailers across all 50 states of the United States and select
international locations. Built on a foundation of regulatory
compliance and human safety, HempFusion’s diverse product portfolio
comprises 46 SKUs including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion’s
wholly-owned subsidiary, Probulin Probiotics, is one of the
fastest-growing probiotics companies in the United States,
according to SPINs reported data. HempFusion’s CBD products are
based on a proprietary Whole Food Hemp Complex™ and are available
in-store or by visiting HempFusion online at www.hempfusion.com or
www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and
Probulin on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to the
Company’s plans, focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Forward-Looking Statements” and “Risk Factors” in the
final long form prospectus of the Company dated December 17, 2020
and available under the Company’s profile on SEDAR at
www.sedar.com. HempFusion undertakes no obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be required
by law. New factors emerge from time to time, and it is not
possible for HempFusion to predict all of them or assess the impact
of each such factor or the extent to which any factor, or
combination of factors, may cause results to differ materially from
those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210112005349/en/
Jason Mitchell, N.D. Chief Executive Officer and Director Email:
ir@hempfusion.com Phone: 416-803-5638
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Mar 2024 to Apr 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Apr 2023 to Apr 2024